nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Ezetimibe—atherosclerosis	0.104	0.152	CbGbCtD
Methylprednisolone—ABCB1—Simvastatin—atherosclerosis	0.0967	0.141	CbGbCtD
Methylprednisolone—ABCB1—Pravastatin—atherosclerosis	0.0947	0.138	CbGbCtD
Methylprednisolone—ABCB1—Lovastatin—atherosclerosis	0.0947	0.138	CbGbCtD
Methylprednisolone—CYP3A4—Rosuvastatin—atherosclerosis	0.0623	0.0909	CbGbCtD
Methylprednisolone—CYP3A4—Ezetimibe—atherosclerosis	0.0623	0.0909	CbGbCtD
Methylprednisolone—CYP3A4—Simvastatin—atherosclerosis	0.058	0.0845	CbGbCtD
Methylprednisolone—CYP3A4—Lovastatin—atherosclerosis	0.0567	0.0827	CbGbCtD
Methylprednisolone—CYP3A4—Pravastatin—atherosclerosis	0.0567	0.0827	CbGbCtD
Methylprednisolone—Amnesia—Rosuvastatin—atherosclerosis	0.00179	0.00703	CcSEcCtD
Methylprednisolone—Vasculitis—Pravastatin—atherosclerosis	0.0017	0.00668	CcSEcCtD
Methylprednisolone—Betamethasone—PLA2G1B—atherosclerosis	0.00165	0.383	CrCbGaD
Methylprednisolone—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00164	0.00644	CcSEcCtD
Methylprednisolone—Skin exfoliation—Niacin—atherosclerosis	0.00161	0.00633	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00161	0.00631	CcSEcCtD
Methylprednisolone—Fluid retention—Niacin—atherosclerosis	0.0016	0.00629	CcSEcCtD
Methylprednisolone—Neuropathy—Pravastatin—atherosclerosis	0.00156	0.00612	CcSEcCtD
Methylprednisolone—Injury—Lovastatin—atherosclerosis	0.00155	0.00609	CcSEcCtD
Methylprednisolone—Oesophagitis—Niacin—atherosclerosis	0.00154	0.00605	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Simvastatin—atherosclerosis	0.00153	0.00602	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00153	0.00602	CcSEcCtD
Methylprednisolone—Breast disorder—Rosuvastatin—atherosclerosis	0.00152	0.00597	CcSEcCtD
Methylprednisolone—Amnesia—Lovastatin—atherosclerosis	0.00152	0.00596	CcSEcCtD
Methylprednisolone—Amnesia—Ezetimibe—atherosclerosis	0.00149	0.00585	CcSEcCtD
Methylprednisolone—Muscular weakness—Rosuvastatin—atherosclerosis	0.00148	0.00583	CcSEcCtD
Methylprednisolone—Pancreatitis—Rosuvastatin—atherosclerosis	0.00142	0.0056	CcSEcCtD
Methylprednisolone—Amnesia—Simvastatin—atherosclerosis	0.00142	0.00557	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Niacin—atherosclerosis	0.00141	0.00553	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00139	0.00544	CcSEcCtD
Methylprednisolone—Injury—Pravastatin—atherosclerosis	0.00131	0.00515	CcSEcCtD
Methylprednisolone—Amnesia—Pravastatin—atherosclerosis	0.00128	0.00504	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00127	0.00499	CcSEcCtD
Methylprednisolone—Breast disorder—Ezetimibe—atherosclerosis	0.00126	0.00496	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00123	0.00484	CcSEcCtD
Methylprednisolone—Muscular weakness—Ezetimibe—atherosclerosis	0.00123	0.00484	CcSEcCtD
Methylprednisolone—Pancreatitis—Lovastatin—atherosclerosis	0.00121	0.00474	CcSEcCtD
Methylprednisolone—Affect lability—Pravastatin—atherosclerosis	0.00119	0.00466	CcSEcCtD
Methylprednisolone—Pancreatitis—Ezetimibe—atherosclerosis	0.00118	0.00465	CcSEcCtD
Methylprednisolone—Muscular weakness—Simvastatin—atherosclerosis	0.00118	0.00462	CcSEcCtD
Methylprednisolone—Rhinitis—Rosuvastatin—atherosclerosis	0.00117	0.00458	CcSEcCtD
Methylprednisolone—Mood swings—Pravastatin—atherosclerosis	0.00114	0.00449	CcSEcCtD
Methylprednisolone—Pancreatitis—Simvastatin—atherosclerosis	0.00113	0.00444	CcSEcCtD
Methylprednisolone—Muscular weakness—Niacin—atherosclerosis	0.00108	0.00424	CcSEcCtD
Methylprednisolone—Infestation—Ezetimibe—atherosclerosis	0.00108	0.00423	CcSEcCtD
Methylprednisolone—Infestation NOS—Ezetimibe—atherosclerosis	0.00108	0.00423	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00108	0.00423	CcSEcCtD
Methylprednisolone—Abdominal distension—Niacin—atherosclerosis	0.00106	0.00418	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00106	0.00418	CcSEcCtD
Methylprednisolone—Muscular weakness—Pravastatin—atherosclerosis	0.00106	0.00418	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00106	0.00415	CcSEcCtD
Methylprednisolone—Abdominal distension—Pravastatin—atherosclerosis	0.00105	0.00412	CcSEcCtD
Methylprednisolone—Arrhythmia—Rosuvastatin—atherosclerosis	0.00104	0.00408	CcSEcCtD
Methylprednisolone—Pancreatitis—Pravastatin—atherosclerosis	0.00102	0.00401	CcSEcCtD
Methylprednisolone—Mental disorder—Rosuvastatin—atherosclerosis	0.00102	0.004	CcSEcCtD
Methylprednisolone—Sweating increased—Pravastatin—atherosclerosis	0.00101	0.00399	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00101	0.00396	CcSEcCtD
Methylprednisolone—Dexamethasone—PLA2G1B—atherosclerosis	0.000961	0.223	CrCbGaD
Methylprednisolone—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00095	0.00373	CcSEcCtD
Methylprednisolone—Weight increased—Pravastatin—atherosclerosis	0.000948	0.00372	CcSEcCtD
Methylprednisolone—Angioedema—Rosuvastatin—atherosclerosis	0.000925	0.00364	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000915	0.0036	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00091	0.00358	CcSEcCtD
Methylprednisolone—Myocardial infarction—Pravastatin—atherosclerosis	0.00091	0.00358	CcSEcCtD
Methylprednisolone—Sweating—Niacin—atherosclerosis	0.000904	0.00355	CcSEcCtD
Methylprednisolone—Angiopathy—Ezetimibe—atherosclerosis	0.000877	0.00345	CcSEcCtD
Methylprednisolone—Immune system disorder—Ezetimibe—atherosclerosis	0.000873	0.00343	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000871	0.00342	CcSEcCtD
Methylprednisolone—Arthralgia—Rosuvastatin—atherosclerosis	0.000862	0.00339	CcSEcCtD
Methylprednisolone—Myalgia—Rosuvastatin—atherosclerosis	0.000862	0.00339	CcSEcCtD
Methylprednisolone—Haemoglobin—Niacin—atherosclerosis	0.000851	0.00334	CcSEcCtD
Methylprednisolone—Rhinitis—Niacin—atherosclerosis	0.000849	0.00334	CcSEcCtD
Methylprednisolone—Mental disorder—Ezetimibe—atherosclerosis	0.000847	0.00333	CcSEcCtD
Methylprednisolone—Haemorrhage—Niacin—atherosclerosis	0.000846	0.00333	CcSEcCtD
Methylprednisolone—Malnutrition—Ezetimibe—atherosclerosis	0.000842	0.00331	CcSEcCtD
Methylprednisolone—Erythema—Ezetimibe—atherosclerosis	0.000842	0.00331	CcSEcCtD
Methylprednisolone—Rhinitis—Pravastatin—atherosclerosis	0.000836	0.00328	CcSEcCtD
Methylprednisolone—Confusional state—Rosuvastatin—atherosclerosis	0.000833	0.00327	CcSEcCtD
Methylprednisolone—Infection—Rosuvastatin—atherosclerosis	0.000821	0.00323	CcSEcCtD
Methylprednisolone—Visual impairment—Niacin—atherosclerosis	0.000816	0.00321	CcSEcCtD
Methylprednisolone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00081	0.00318	CcSEcCtD
Methylprednisolone—Mental disorder—Simvastatin—atherosclerosis	0.000808	0.00317	CcSEcCtD
Methylprednisolone—Visual impairment—Pravastatin—atherosclerosis	0.000803	0.00316	CcSEcCtD
Methylprednisolone—Erythema—Simvastatin—atherosclerosis	0.000803	0.00315	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000796	0.00313	CcSEcCtD
Methylprednisolone—Eye disorder—Niacin—atherosclerosis	0.000791	0.00311	CcSEcCtD
Methylprednisolone—Angioedema—Lovastatin—atherosclerosis	0.000784	0.00308	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000781	0.00307	CcSEcCtD
Methylprednisolone—Malaise—Lovastatin—atherosclerosis	0.000774	0.00304	CcSEcCtD
Methylprednisolone—Cardiac disorder—Pravastatin—atherosclerosis	0.000774	0.00304	CcSEcCtD
Methylprednisolone—Vertigo—Lovastatin—atherosclerosis	0.000771	0.00303	CcSEcCtD
Methylprednisolone—Angioedema—Ezetimibe—atherosclerosis	0.000769	0.00302	CcSEcCtD
Methylprednisolone—Angiopathy—Niacin—atherosclerosis	0.000768	0.00302	CcSEcCtD
Methylprednisolone—Malaise—Ezetimibe—atherosclerosis	0.000759	0.00298	CcSEcCtD
Methylprednisolone—Arrhythmia—Niacin—atherosclerosis	0.000756	0.00297	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000753	0.00296	CcSEcCtD
Methylprednisolone—Insomnia—Rosuvastatin—atherosclerosis	0.000747	0.00294	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000745	0.00293	CcSEcCtD
Methylprednisolone—Arrhythmia—Pravastatin—atherosclerosis	0.000745	0.00293	CcSEcCtD
Methylprednisolone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000742	0.00292	CcSEcCtD
Methylprednisolone—Erythema—Niacin—atherosclerosis	0.000737	0.0029	CcSEcCtD
Methylprednisolone—Malnutrition—Niacin—atherosclerosis	0.000737	0.0029	CcSEcCtD
Methylprednisolone—Angioedema—Simvastatin—atherosclerosis	0.000733	0.00288	CcSEcCtD
Methylprednisolone—Arthralgia—Lovastatin—atherosclerosis	0.00073	0.00287	CcSEcCtD
Methylprednisolone—Myalgia—Lovastatin—atherosclerosis	0.00073	0.00287	CcSEcCtD
Methylprednisolone—Anxiety—Lovastatin—atherosclerosis	0.000728	0.00286	CcSEcCtD
Methylprednisolone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000727	0.00286	CcSEcCtD
Methylprednisolone—Hypertension—Ezetimibe—atherosclerosis	0.000727	0.00286	CcSEcCtD
Methylprednisolone—Malaise—Simvastatin—atherosclerosis	0.000724	0.00284	CcSEcCtD
Methylprednisolone—Discomfort—Lovastatin—atherosclerosis	0.000722	0.00284	CcSEcCtD
Methylprednisolone—Vertigo—Simvastatin—atherosclerosis	0.000721	0.00283	CcSEcCtD
Methylprednisolone—Arthralgia—Ezetimibe—atherosclerosis	0.000716	0.00282	CcSEcCtD
Methylprednisolone—Myalgia—Ezetimibe—atherosclerosis	0.000716	0.00282	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000712	0.0028	CcSEcCtD
Methylprednisolone—Discomfort—Ezetimibe—atherosclerosis	0.000708	0.00278	CcSEcCtD
Methylprednisolone—Confusional state—Lovastatin—atherosclerosis	0.000706	0.00277	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Lovastatin—atherosclerosis	0.0007	0.00275	CcSEcCtD
Methylprednisolone—Infection—Lovastatin—atherosclerosis	0.000696	0.00273	CcSEcCtD
Methylprednisolone—Confusional state—Ezetimibe—atherosclerosis	0.000693	0.00272	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000687	0.0027	CcSEcCtD
Methylprednisolone—Myalgia—Simvastatin—atherosclerosis	0.000683	0.00269	CcSEcCtD
Methylprednisolone—Arthralgia—Simvastatin—atherosclerosis	0.000683	0.00269	CcSEcCtD
Methylprednisolone—Infection—Ezetimibe—atherosclerosis	0.000682	0.00268	CcSEcCtD
Methylprednisolone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000681	0.00268	CcSEcCtD
Methylprednisolone—Anxiety—Simvastatin—atherosclerosis	0.000681	0.00268	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000676	0.00266	CcSEcCtD
Methylprednisolone—Discomfort—Simvastatin—atherosclerosis	0.000675	0.00265	CcSEcCtD
Methylprednisolone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000674	0.00265	CcSEcCtD
Methylprednisolone—Angioedema—Niacin—atherosclerosis	0.000673	0.00265	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000673	0.00265	CcSEcCtD
Methylprednisolone—Skin disorder—Ezetimibe—atherosclerosis	0.000667	0.00262	CcSEcCtD
Methylprednisolone—Angioedema—Pravastatin—atherosclerosis	0.000663	0.00261	CcSEcCtD
Methylprednisolone—Vertigo—Niacin—atherosclerosis	0.000662	0.0026	CcSEcCtD
Methylprednisolone—Syncope—Niacin—atherosclerosis	0.000661	0.0026	CcSEcCtD
Methylprednisolone—Confusional state—Simvastatin—atherosclerosis	0.00066	0.0026	CcSEcCtD
Methylprednisolone—Urticaria—Rosuvastatin—atherosclerosis	0.000656	0.00258	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000655	0.00257	CcSEcCtD
Methylprednisolone—Malaise—Pravastatin—atherosclerosis	0.000654	0.00257	CcSEcCtD
Methylprednisolone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000653	0.00257	CcSEcCtD
Methylprednisolone—Vertigo—Pravastatin—atherosclerosis	0.000652	0.00256	CcSEcCtD
Methylprednisolone—Infection—Simvastatin—atherosclerosis	0.000651	0.00256	CcSEcCtD
Methylprednisolone—Loss of consciousness—Niacin—atherosclerosis	0.000648	0.00255	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000638	0.00251	CcSEcCtD
Methylprednisolone—Insomnia—Lovastatin—atherosclerosis	0.000633	0.00249	CcSEcCtD
Methylprednisolone—Paraesthesia—Lovastatin—atherosclerosis	0.000629	0.00247	CcSEcCtD
Methylprednisolone—Arthralgia—Niacin—atherosclerosis	0.000627	0.00247	CcSEcCtD
Methylprednisolone—Myalgia—Niacin—atherosclerosis	0.000627	0.00247	CcSEcCtD
Methylprednisolone—Hypertension—Pravastatin—atherosclerosis	0.000626	0.00246	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000626	0.00246	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000623	0.00245	CcSEcCtD
Methylprednisolone—Insomnia—Ezetimibe—atherosclerosis	0.000621	0.00244	CcSEcCtD
Methylprednisolone—Myalgia—Pravastatin—atherosclerosis	0.000618	0.00243	CcSEcCtD
Methylprednisolone—Arthralgia—Pravastatin—atherosclerosis	0.000618	0.00243	CcSEcCtD
Methylprednisolone—Paraesthesia—Ezetimibe—atherosclerosis	0.000617	0.00242	CcSEcCtD
Methylprednisolone—Dyspepsia—Lovastatin—atherosclerosis	0.000616	0.00242	CcSEcCtD
Methylprednisolone—Anxiety—Pravastatin—atherosclerosis	0.000616	0.00242	CcSEcCtD
Methylprednisolone—Discomfort—Pravastatin—atherosclerosis	0.00061	0.0024	CcSEcCtD
Methylprednisolone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000609	0.00239	CcSEcCtD
Methylprednisolone—Dyspepsia—Ezetimibe—atherosclerosis	0.000605	0.00238	CcSEcCtD
Methylprednisolone—Fatigue—Lovastatin—atherosclerosis	0.000604	0.00237	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Niacin—atherosclerosis	0.000601	0.00236	CcSEcCtD
Methylprednisolone—Confusional state—Pravastatin—atherosclerosis	0.000597	0.00235	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000597	0.00235	CcSEcCtD
Methylprednisolone—Asthenia—Rosuvastatin—atherosclerosis	0.000593	0.00233	CcSEcCtD
Methylprednisolone—Insomnia—Simvastatin—atherosclerosis	0.000592	0.00233	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000592	0.00233	CcSEcCtD
Methylprednisolone—Fatigue—Ezetimibe—atherosclerosis	0.000592	0.00233	CcSEcCtD
Methylprednisolone—Shock—Niacin—atherosclerosis	0.000592	0.00233	CcSEcCtD
Methylprednisolone—Infection—Pravastatin—atherosclerosis	0.000588	0.00231	CcSEcCtD
Methylprednisolone—Paraesthesia—Simvastatin—atherosclerosis	0.000588	0.00231	CcSEcCtD
Methylprednisolone—Tachycardia—Niacin—atherosclerosis	0.000587	0.00231	CcSEcCtD
Methylprednisolone—Pruritus—Rosuvastatin—atherosclerosis	0.000585	0.0023	CcSEcCtD
Methylprednisolone—Skin disorder—Niacin—atherosclerosis	0.000584	0.0023	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Niacin—atherosclerosis	0.000581	0.00229	CcSEcCtD
Methylprednisolone—Feeling abnormal—Lovastatin—atherosclerosis	0.000577	0.00227	CcSEcCtD
Methylprednisolone—Dyspepsia—Simvastatin—atherosclerosis	0.000577	0.00227	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000573	0.00225	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000572	0.00225	CcSEcCtD
Methylprednisolone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000566	0.00222	CcSEcCtD
Methylprednisolone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000565	0.00222	CcSEcCtD
Methylprednisolone—Fatigue—Simvastatin—atherosclerosis	0.000565	0.00222	CcSEcCtD
Methylprednisolone—Hypotension—Niacin—atherosclerosis	0.000562	0.00221	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000562	0.00221	CcSEcCtD
Methylprednisolone—Urticaria—Lovastatin—atherosclerosis	0.000556	0.00219	CcSEcCtD
Methylprednisolone—Abdominal pain—Lovastatin—atherosclerosis	0.000554	0.00218	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000548	0.00215	CcSEcCtD
Methylprednisolone—Dizziness—Rosuvastatin—atherosclerosis	0.000546	0.00215	CcSEcCtD
Methylprednisolone—Urticaria—Ezetimibe—atherosclerosis	0.000546	0.00214	CcSEcCtD
Methylprednisolone—Insomnia—Niacin—atherosclerosis	0.000544	0.00214	CcSEcCtD
Methylprednisolone—Abdominal pain—Ezetimibe—atherosclerosis	0.000543	0.00213	CcSEcCtD
Methylprednisolone—Paraesthesia—Niacin—atherosclerosis	0.00054	0.00212	CcSEcCtD
Methylprednisolone—Feeling abnormal—Simvastatin—atherosclerosis	0.00054	0.00212	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000539	0.00212	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000536	0.00211	CcSEcCtD
Methylprednisolone—Insomnia—Pravastatin—atherosclerosis	0.000536	0.0021	CcSEcCtD
Methylprednisolone—Paraesthesia—Pravastatin—atherosclerosis	0.000532	0.00209	CcSEcCtD
Methylprednisolone—Dyspepsia—Niacin—atherosclerosis	0.000529	0.00208	CcSEcCtD
Methylprednisolone—Dyspepsia—Pravastatin—atherosclerosis	0.000521	0.00205	CcSEcCtD
Methylprednisolone—Rash—Rosuvastatin—atherosclerosis	0.000521	0.00205	CcSEcCtD
Methylprednisolone—Dermatitis—Rosuvastatin—atherosclerosis	0.00052	0.00205	CcSEcCtD
Methylprednisolone—Urticaria—Simvastatin—atherosclerosis	0.00052	0.00205	CcSEcCtD
Methylprednisolone—Abdominal pain—Simvastatin—atherosclerosis	0.000518	0.00203	CcSEcCtD
Methylprednisolone—Headache—Rosuvastatin—atherosclerosis	0.000518	0.00203	CcSEcCtD
Methylprednisolone—Hypersensitivity—Lovastatin—atherosclerosis	0.000516	0.00203	CcSEcCtD
Methylprednisolone—Fatigue—Pravastatin—atherosclerosis	0.000511	0.00201	CcSEcCtD
Methylprednisolone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000506	0.00199	CcSEcCtD
Methylprednisolone—Asthenia—Lovastatin—atherosclerosis	0.000502	0.00197	CcSEcCtD
Methylprednisolone—Pruritus—Lovastatin—atherosclerosis	0.000495	0.00195	CcSEcCtD
Methylprednisolone—Asthenia—Ezetimibe—atherosclerosis	0.000493	0.00194	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Niacin—atherosclerosis	0.000492	0.00193	CcSEcCtD
Methylprednisolone—Nausea—Rosuvastatin—atherosclerosis	0.000491	0.00193	CcSEcCtD
Methylprednisolone—Feeling abnormal—Pravastatin—atherosclerosis	0.000488	0.00192	CcSEcCtD
Methylprednisolone—Pruritus—Ezetimibe—atherosclerosis	0.000486	0.00191	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000484	0.0019	CcSEcCtD
Methylprednisolone—Hypersensitivity—Simvastatin—atherosclerosis	0.000483	0.0019	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000482	0.00874	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Lovastatin—atherosclerosis	0.000479	0.00188	CcSEcCtD
Methylprednisolone—Urticaria—Niacin—atherosclerosis	0.000478	0.00188	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.000476	0.00865	CbGpPWpGaD
Methylprednisolone—Abdominal pain—Niacin—atherosclerosis	0.000475	0.00187	CcSEcCtD
Methylprednisolone—Urticaria—Pravastatin—atherosclerosis	0.00047	0.00185	CcSEcCtD
Methylprednisolone—Asthenia—Simvastatin—atherosclerosis	0.00047	0.00185	CcSEcCtD
Methylprednisolone—Diarrhoea—Ezetimibe—atherosclerosis	0.00047	0.00185	CcSEcCtD
Methylprednisolone—Abdominal pain—Pravastatin—atherosclerosis	0.000468	0.00184	CcSEcCtD
Methylprednisolone—Medroxyprogesterone Acetate—ESR1—atherosclerosis	0.000467	0.108	CrCbGaD
Methylprednisolone—Pruritus—Simvastatin—atherosclerosis	0.000463	0.00182	CcSEcCtD
Methylprednisolone—Dizziness—Lovastatin—atherosclerosis	0.000463	0.00182	CcSEcCtD
Methylprednisolone—Dizziness—Ezetimibe—atherosclerosis	0.000454	0.00179	CcSEcCtD
Methylprednisolone—Diarrhoea—Simvastatin—atherosclerosis	0.000448	0.00176	CcSEcCtD
Methylprednisolone—Vomiting—Lovastatin—atherosclerosis	0.000445	0.00175	CcSEcCtD
Methylprednisolone—Hypersensitivity—Niacin—atherosclerosis	0.000443	0.00174	CcSEcCtD
Methylprednisolone—Rash—Lovastatin—atherosclerosis	0.000442	0.00174	CcSEcCtD
Methylprednisolone—Dermatitis—Lovastatin—atherosclerosis	0.000441	0.00173	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.000439	0.00797	CbGpPWpGaD
Methylprednisolone—Headache—Lovastatin—atherosclerosis	0.000439	0.00172	CcSEcCtD
Methylprednisolone—Vomiting—Ezetimibe—atherosclerosis	0.000437	0.00172	CcSEcCtD
Methylprednisolone—Hypersensitivity—Pravastatin—atherosclerosis	0.000436	0.00171	CcSEcCtD
Methylprednisolone—Dizziness—Simvastatin—atherosclerosis	0.000433	0.0017	CcSEcCtD
Methylprednisolone—Rash—Ezetimibe—atherosclerosis	0.000433	0.0017	CcSEcCtD
Methylprednisolone—Dermatitis—Ezetimibe—atherosclerosis	0.000433	0.0017	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.000432	0.00783	CbGpPWpGaD
Methylprednisolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.000432	0.00783	CbGpPWpGaD
Methylprednisolone—Asthenia—Niacin—atherosclerosis	0.000431	0.0017	CcSEcCtD
Methylprednisolone—Headache—Ezetimibe—atherosclerosis	0.00043	0.00169	CcSEcCtD
Methylprednisolone—Dexamethasone—NOS2—atherosclerosis	0.000429	0.0995	CrCbGaD
Methylprednisolone—Pruritus—Niacin—atherosclerosis	0.000425	0.00167	CcSEcCtD
Methylprednisolone—Asthenia—Pravastatin—atherosclerosis	0.000425	0.00167	CcSEcCtD
Methylprednisolone—Pruritus—Pravastatin—atherosclerosis	0.000419	0.00165	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000417	0.00756	CbGpPWpGaD
Methylprednisolone—Vomiting—Simvastatin—atherosclerosis	0.000416	0.00164	CcSEcCtD
Methylprednisolone—Nausea—Lovastatin—atherosclerosis	0.000416	0.00163	CcSEcCtD
Methylprednisolone—Rash—Simvastatin—atherosclerosis	0.000413	0.00162	CcSEcCtD
Methylprednisolone—Dermatitis—Simvastatin—atherosclerosis	0.000413	0.00162	CcSEcCtD
Methylprednisolone—Diarrhoea—Niacin—atherosclerosis	0.000411	0.00162	CcSEcCtD
Methylprednisolone—Headache—Simvastatin—atherosclerosis	0.00041	0.00161	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.000409	0.00743	CbGpPWpGaD
Methylprednisolone—Nausea—Ezetimibe—atherosclerosis	0.000408	0.0016	CcSEcCtD
Methylprednisolone—Diarrhoea—Pravastatin—atherosclerosis	0.000405	0.00159	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000404	0.00732	CbGpPWpGaD
Methylprednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.000402	0.00729	CbGpPWpGaD
Methylprednisolone—Dizziness—Niacin—atherosclerosis	0.000398	0.00156	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000398	0.00721	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.000394	0.00715	CbGpPWpGaD
Methylprednisolone—Dizziness—Pravastatin—atherosclerosis	0.000392	0.00154	CcSEcCtD
Methylprednisolone—Nausea—Simvastatin—atherosclerosis	0.000389	0.00153	CcSEcCtD
Methylprednisolone—Vomiting—Niacin—atherosclerosis	0.000382	0.0015	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—AHR—atherosclerosis	0.00038	0.0069	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000379	0.00688	CbGpPWpGaD
Methylprednisolone—Rash—Niacin—atherosclerosis	0.000379	0.00149	CcSEcCtD
Methylprednisolone—Dermatitis—Niacin—atherosclerosis	0.000379	0.00149	CcSEcCtD
Methylprednisolone—Headache—Niacin—atherosclerosis	0.000377	0.00148	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.000377	0.00683	CbGpPWpGaD
Methylprednisolone—Vomiting—Pravastatin—atherosclerosis	0.000376	0.00148	CcSEcCtD
Methylprednisolone—Rash—Pravastatin—atherosclerosis	0.000373	0.00147	CcSEcCtD
Methylprednisolone—Dermatitis—Pravastatin—atherosclerosis	0.000373	0.00147	CcSEcCtD
Methylprednisolone—Headache—Pravastatin—atherosclerosis	0.000371	0.00146	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.000362	0.00658	CbGpPWpGaD
Methylprednisolone—Nausea—Niacin—atherosclerosis	0.000357	0.0014	CcSEcCtD
Methylprednisolone—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.000354	0.00643	CbGpPWpGaD
Methylprednisolone—Nausea—Pravastatin—atherosclerosis	0.000352	0.00138	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000344	0.00623	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.000341	0.00619	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000341	0.00619	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000338	0.00613	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000337	0.00612	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000333	0.00603	CbGpPWpGaD
Methylprednisolone—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000331	0.006	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.000324	0.00588	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000315	0.00571	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000311	0.00565	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000306	0.00555	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000302	0.00547	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.0003	0.00544	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000287	0.0052	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.000283	0.00514	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000283	0.00513	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.00028	0.00508	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000279	0.00506	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.000272	0.00494	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.000265	0.0048	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000264	0.00479	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.000261	0.00474	CbGpPWpGaD
Methylprednisolone—Triamcinolone—PTGS2—atherosclerosis	0.000259	0.06	CrCbGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.000253	0.00458	CbGpPWpGaD
Methylprednisolone—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000251	0.00455	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000249	0.00451	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000248	0.0045	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL17A—atherosclerosis	0.000242	0.00439	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000236	0.00427	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000233	0.00423	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000231	0.0042	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00023	0.00417	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.00023	0.00416	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000229	0.00416	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.000226	0.0041	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD40—atherosclerosis	0.000214	0.00389	CbGpPWpGaD
Methylprednisolone—Betamethasone—PTGS2—atherosclerosis	0.000212	0.0491	CrCbGaD
Methylprednisolone—Prednisone—ALB—atherosclerosis	0.000209	0.0485	CrCbGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.000204	0.0037	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000203	0.00367	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000202	0.00366	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000198	0.0036	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	0.000196	0.00356	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000194	0.00351	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.000192	0.00348	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000184	0.00334	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000178	0.00323	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000178	0.00322	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000175	0.00317	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000173	0.00313	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000172	0.00313	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000169	0.00307	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000167	0.00302	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	0.000164	0.00298	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL10—atherosclerosis	0.000164	0.00298	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000162	0.00295	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	0.000156	0.00283	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—FASLG—atherosclerosis	0.000153	0.00277	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000147	0.00267	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	0.000146	0.00264	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000145	0.00264	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—INS—atherosclerosis	0.000144	0.00262	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000143	0.00259	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000142	0.00259	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000141	0.00255	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.00014	0.00253	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000139	0.00252	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000138	0.00251	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000137	0.00249	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000133	0.00241	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000132	0.00239	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00013	0.00236	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000125	0.00226	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—atherosclerosis	0.000123	0.0286	CrCbGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	0.000123	0.00222	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000122	0.00221	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00012	0.00218	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000114	0.00206	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000109	0.00198	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000105	0.00191	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000104	0.00188	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000103	0.00186	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	9.72e-05	0.00176	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	9.71e-05	0.00176	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IFNG—atherosclerosis	9.67e-05	0.00175	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	9.31e-05	0.00169	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	9.12e-05	0.00166	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—STAT3—atherosclerosis	9.03e-05	0.00164	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	8.99e-05	0.00163	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	8.69e-05	0.00158	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1B—atherosclerosis	8.62e-05	0.00156	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	8.61e-05	0.00156	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	8.5e-05	0.00154	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	8.46e-05	0.00154	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	8.43e-05	0.00153	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	8.42e-05	0.00153	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TGFB1—atherosclerosis	8.37e-05	0.00152	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	7.88e-05	0.00143	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—atherosclerosis	7.82e-05	0.00142	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	7.8e-05	0.00142	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	7.54e-05	0.00137	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	7.3e-05	0.00132	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.02e-05	0.00127	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	6.76e-05	0.00123	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.75e-05	0.00123	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	6.7e-05	0.00122	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	6.5e-05	0.00118	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	6.37e-05	0.00116	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—atherosclerosis	6.31e-05	0.00114	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—atherosclerosis	6.26e-05	0.00114	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LDLRAP1—atherosclerosis	6.26e-05	0.00113	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	5.89e-05	0.00107	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLTP—atherosclerosis	5.88e-05	0.00107	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	5.54e-05	0.00101	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	5.52e-05	0.001	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	5.45e-05	0.000989	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	5.44e-05	0.000986	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	5.38e-05	0.000976	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	5.38e-05	0.000975	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	5.36e-05	0.000973	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG8—atherosclerosis	5.1e-05	0.000925	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LTA4H—atherosclerosis	5.1e-05	0.000925	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	5e-05	0.000907	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PARP1—atherosclerosis	4.94e-05	0.000896	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.84e-05	0.000879	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR2—atherosclerosis	4.68e-05	0.000849	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	4.57e-05	0.00083	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.41e-05	0.000799	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG1—atherosclerosis	4.03e-05	0.000731	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.97e-05	0.00072	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.9e-05	0.000708	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.85e-05	0.000699	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LCAT—atherosclerosis	3.79e-05	0.000688	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FABP4—atherosclerosis	3.79e-05	0.000688	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SIRT1—atherosclerosis	3.77e-05	0.000683	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	3.75e-05	0.00068	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOA4—atherosclerosis	3.72e-05	0.000675	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP7A1—atherosclerosis	3.65e-05	0.000663	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLTP—atherosclerosis	3.62e-05	0.000657	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	3.6e-05	0.000654	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.46e-05	0.000627	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.41e-05	0.000618	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP27A1—atherosclerosis	3.38e-05	0.000613	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.31e-05	0.000601	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.31e-05	0.0006	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALOX5AP—atherosclerosis	3.2e-05	0.000581	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALOX15—atherosclerosis	3.2e-05	0.000581	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLA2G2A—atherosclerosis	3.2e-05	0.000581	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOA2—atherosclerosis	3.2e-05	0.000581	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG5—atherosclerosis	3.16e-05	0.000574	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.14e-05	0.00057	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.14e-05	0.00057	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARA—atherosclerosis	3.13e-05	0.000568	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.09e-05	0.00056	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LPA—atherosclerosis	3.05e-05	0.000554	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BGN—atherosclerosis	2.96e-05	0.000537	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOA5—atherosclerosis	2.93e-05	0.000531	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR1—atherosclerosis	2.84e-05	0.000515	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLA2G1B—atherosclerosis	2.82e-05	0.000511	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.79e-05	0.000507	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALOX5—atherosclerosis	2.72e-05	0.000494	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.62e-05	0.000475	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—atherosclerosis	2.59e-05	0.00047	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.48e-05	0.000451	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NAMPT—atherosclerosis	2.44e-05	0.000443	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LIPC—atherosclerosis	2.43e-05	0.00044	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOC3—atherosclerosis	2.41e-05	0.000438	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LDLR—atherosclerosis	2.4e-05	0.000435	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CETP—atherosclerosis	2.34e-05	0.000425	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FABP4—atherosclerosis	2.33e-05	0.000424	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LCAT—atherosclerosis	2.33e-05	0.000424	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	2.33e-05	0.000423	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.3e-05	0.000417	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOA4—atherosclerosis	2.29e-05	0.000416	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.25e-05	0.000408	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SCARB1—atherosclerosis	2.24e-05	0.000407	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMGCR—atherosclerosis	2.12e-05	0.000384	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.08e-05	0.000378	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.08e-05	0.000377	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.97e-05	0.000358	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.97e-05	0.000358	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.97e-05	0.000358	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.97e-05	0.000358	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.95e-05	0.000354	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCA1—atherosclerosis	1.89e-05	0.000342	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LPA—atherosclerosis	1.88e-05	0.000341	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BGN—atherosclerosis	1.82e-05	0.000331	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOA5—atherosclerosis	1.8e-05	0.000327	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.74e-05	0.000315	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.68e-05	0.000304	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—atherosclerosis	1.62e-05	0.000294	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOB—atherosclerosis	1.55e-05	0.000281	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MAPK3—atherosclerosis	1.52e-05	0.000275	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—atherosclerosis	1.51e-05	0.000274	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.5e-05	0.000273	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LIPC—atherosclerosis	1.5e-05	0.000271	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOC3—atherosclerosis	1.49e-05	0.00027	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LPL—atherosclerosis	1.48e-05	0.000269	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LDLR—atherosclerosis	1.48e-05	0.000268	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPX1—atherosclerosis	1.44e-05	0.000262	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CETP—atherosclerosis	1.44e-05	0.000262	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CD36—atherosclerosis	1.41e-05	0.000255	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.38e-05	0.000251	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—atherosclerosis	1.33e-05	0.000242	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARA—atherosclerosis	1.31e-05	0.000237	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.3e-05	0.000237	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AGT—atherosclerosis	1.27e-05	0.00023	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOE—atherosclerosis	1.24e-05	0.000225	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAV1—atherosclerosis	1.23e-05	0.000223	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOA1—atherosclerosis	1.23e-05	0.000223	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.16e-05	0.000211	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.12e-05	0.000203	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—atherosclerosis	1.08e-05	0.000196	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—INS—atherosclerosis	1.06e-05	0.000192	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—atherosclerosis	1.02e-05	0.000186	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.98e-06	0.000181	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—atherosclerosis	9.72e-06	0.000176	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOB—atherosclerosis	9.56e-06	0.000173	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NOS3—atherosclerosis	9.3e-06	0.000169	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—atherosclerosis	9.3e-06	0.000169	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LPL—atherosclerosis	9.12e-06	0.000166	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPX1—atherosclerosis	8.9e-06	0.000162	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CD36—atherosclerosis	8.67e-06	0.000157	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—atherosclerosis	8.51e-06	0.000154	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—atherosclerosis	8.21e-06	0.000149	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARA—atherosclerosis	8.06e-06	0.000146	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AGT—atherosclerosis	7.81e-06	0.000142	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOE—atherosclerosis	7.65e-06	0.000139	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAV1—atherosclerosis	7.58e-06	0.000137	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOA1—atherosclerosis	7.56e-06	0.000137	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.9e-06	0.000125	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—atherosclerosis	6.66e-06	0.000121	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—INS—atherosclerosis	6.53e-06	0.000119	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—atherosclerosis	5.99e-06	0.000109	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NOS3—atherosclerosis	5.73e-06	0.000104	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—atherosclerosis	5.24e-06	9.51e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—atherosclerosis	4.27e-06	7.76e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—atherosclerosis	2.63e-06	4.78e-05	CbGpPWpGaD
